TRIO History
Our Executive
Trials
Starts with "C" or "K"
Glossary
100

Integrity, Teamwork, Passion

What are the TRIO Core Values?

100

Received his MD and his Medical Oncology specialization from the Universidad de la República in Montevideo, Uruguay

Who is Rodrigo Fresco?

100

Sponsor of TRIO033

What is Novartis?

100

An abnormal growth of cells which tend to proliferate in an uncontrolled way

What is Cancer?

100

CDMS

What is Clinical Data Management System?

200

“Advancing translational cancer research by bringing forward innovative and novel targeted therapeutic concepts into the clinical trial setting.”

What is the TRIO Mission Statement?

200

Once the Chief Operating Officer for Isotechnika Pharma Inc.

Who is Launa Aspeslet?

200

New sponsor of the "Medivation" trials

What is Pfizer?

200

Abbreviation for Key Risk Indicator

What is KRI?

200

GCP

What is Good Clinical Practice?

300

Original name in 1997

What is BCIRG (Breast Cancer International Research Group)?

300

Worked in Canada from 1998 to 2001 as a Clinical Research Associate and Project Manager

Who is Veronique Moineau?

300

Currently running non-interventional trial

What is TRIO032?

300

Paper or electronic data collection instrument specifically used in clinical trial research.

What is Case Report Form or CRF?

300

IWRS

What is Interactive Web Response System?

400

TRIO Chairman & Executive Director

Who is Dr. Dennis Slamon?

400

Holds a degree in Mathematics and Chemistry from the University of Paris Diderot

Who is Huu Phu Le?

400

Headquarters location of TRIO033 sponsor

What is Switzerland (Basel - Novartis)?

400

"These are my breast cancer cells."

Who is Kimberley?

400

ICH

What is International Conference on Harmonization?

500

Year of the name change to TRIO

What is 2011?

500

Worked from 1997 to 2001 at Aventis Pharma, first as a Clinical Data Validator and then as an International Study Manager for a Phase 3 registration trial

Who is Valerie Bee?

500

"A Multicenter, Multinational, Randomized, Double-Blind, Phase III Study of IMC-1121B Plus Docetaxel Versus Placebo Plus Docetaxel in Previously Untreated Patients With HER2-Negative, Unresectable, Locally-Recurrent or Metastatic Breast Cancer (ROSE)"

What is TRIO012?

500

March MyTRIO Portal featured employee.

Who is David Cabaribere.

500

SUSAR

What is "Suspected Unexpected Serious Adverse Reaction"?

M
e
n
u